After rigorous selection, PLCH2, PRKCQ, and SMG1 were selected based on their satisfactory performance criteria, exhibiting an AUC > 0.8 and statistically significant differences in expression between the AAA and control groups. This evidence concerns the gene PLCH2 and triple-A syndrome.